Dr. Leahy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3501 Civic Center Blvd
Philadelphia, PA 19104Phone+1 215-590-1221
Summary
- Dr. Allison Leahy is a pediatric hematologist/oncologist in Philadelphia, PA and is affiliated with Children's Hospital of Philadelphia. She received her medical degree from SUNY Upstate Medical University. She specializes in pediatric hematologic oncology and is experienced in leukemia, CAR T cell therapy, pediatric hematopoietic stem cell transplantation, and patient reported outcomes.
Education & Training
- Children's Hospital of PhiladelphiaFellowship, Pediatric Hematology/Oncology, 2015 - 2018
- Children's Hospital of PhiladelphiaResidency, Pediatrics, 2012 - 2015
- SUNY Upstate Medical UniversityClass of 2012
Certifications & Licensure
- PA State Medical License 2012 - 2024
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- 470 citationsAdverse Symptom Event Reporting by Patients vs Clinicians: Relationships With Clinical OutcomesEthan Basch, Xiaoyu Jia, Glenn Heller, Allison Barz, Laura Sit
Journal of the National Cancer Institute. 2009-12-02 - 717 citationsDevelopment of the National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)Ethan Basch, Bryce B. Reeve, Sandra A. Mitchell, Steven B. Clauser, Lori M. Minasian
Journal of the National Cancer Institute. 2014-09-01 - 11 citationsImpact of poverty and neighborhood opportunity on outcomes for children treated with CD19-directed CAR T-cell therapy.Haley Newman, Yimei Li, Hongyan Liu, Regina M Myers, Vicky Tam
Blood. 2023-02-09
Press Mentions
- CAR T-cell Therapy Outcomes Similar Across Different Socioeconomic Levels Among Patients with Pediatric ALLNovember 18th, 2022
- CAR T-cell Therapy Performs Just as Well in Poor as in Wealthier KidsNovember 16th, 2022
- Patient-Reported Outcomes in Pediatric CancerSeptember 5th, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: